AA
VCNX

Ancora Advisors’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Ancora Advisors’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10
Closed -$2K – 2229
2022
Q2 		$2K Hold
10
– – ﹤0.01% 1991
2022
Q1 		$3K Hold
10
– – ﹤0.01% 2087
2021
Q4 		$2K Hold
10
– – ﹤0.01% 2220
2021
Q3 		$4K Hold
10
– – ﹤0.01% 1965
2021
Q2 		$6K Hold
10
– – ﹤0.01% 1668
2021
Q1 		$6K Buy
+10
New +$6.43K ﹤0.01% 1534

Other funds holding VCNX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Ancora Advisors's VCNX Position: Q3 2022 in Review

Ancora Advisors sold out of Vaccinex, Inc. Common Stock (VCNX) in Q3 2022, closing a stake of 10 shares — an estimated $2K sold.

Ancora Advisors first reported a position in VCNX in Q1 2021 and held it in 6 quarters. The position peaked at $6K in Q2 2021. 22 funds tracked by Wall St. Rank hold VCNX as of Q3 2022.

  • Ancora Advisors reported no remaining Vaccinex, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ancora Advisors sold 10 Vaccinex, Inc. Common Stock shares in Q3 2022, an estimated $2K.
  • Ancora Advisors first reported a position in Vaccinex, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Ancora Advisors's Vaccinex, Inc. Common Stock position peaked at $6K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q3 2022.

Based on Ancora Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.